{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:55:35Z","timestamp":1790546135970,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["GUIMBE22Y7"],"award-info":[{"award-number":["GUIMBE22Y7"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK72482"],"award-info":[{"award-number":["P30DK72482"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL155119"],"award-info":[{"award-number":["R01HL155119"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jcf.2024.07.010","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T21:24:15Z","timestamp":1721424255000},"page":"959-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)"],"prefix":"10.1016","volume":"23","author":[{"given":"Elizabeth","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0875-4750","authenticated-orcid":false,"given":"William T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Guimbellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Bliton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vamsee","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4052-1524","authenticated-orcid":false,"given":"Gabriela R.","family":"Oates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2024.07.010_bib0001","series-title":"The health consequences of smoking\u201450 years of progress: a report of the surgeon general","first-page":"2","year":"2014"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.010_bib0002","doi-asserted-by":"crossref","first-page":"e1439","DOI":"10.1542\/peds.2015-3110","article-title":"Protecting children from tobacco, nicotine, and tobacco smoke","volume":"136","author":"Farber","year":"2015","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.010_bib0003","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archpedi.159.5.450","article-title":"Screening for children's exposure to environmental tobacco smoke in a pediatric primary care setting","volume":"159","author":"Groner","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jcf.2024.07.010_bib0004","first-page":"709","volume":"xvii","year":"2006"},{"key":"10.1016\/j.jcf.2024.07.010_bib0005","first-page":"704","volume":"xv","year":"2010"},{"issue":"11","key":"10.1016\/j.jcf.2024.07.010_bib0006","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1164\/rccm.200812-1920OC","article-title":"Acute and short-term effects of secondhand smoke on lung function and cytokine production","volume":"179","author":"Flouris","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/tc.2003.003889","article-title":"Households contaminated by environmental tobacco smoke: sources of infant exposures","volume":"13","author":"Matt","year":"2004","journal-title":"Tob Control"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0008","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/tc.2010.037382","article-title":"When smokers move out and non-smokers move in: residential thirdhand smoke pollution and exposure","volume":"20","author":"Matt","year":"2011","journal-title":"Tob Control"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.010_bib0009","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/tobaccocontrol-2016-053119","article-title":"When smokers quit: exposure to nicotine and carcinogens persists from thirdhand smoke pollution","volume":"26","author":"Matt","year":"2016","journal-title":"Tob Control"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/003335491613100206","article-title":"Thirdhand smoke: state of the science and a call for policy expansion","volume":"131","author":"Northrup","year":"2016","journal-title":"Public Health Rep"},{"key":"10.1016\/j.jcf.2024.07.010_bib0011","doi-asserted-by":"crossref","DOI":"10.1177\/1179173X18823493","article-title":"Nicotine on children's hands: limited protection of smoking bans and initial clinical findings","volume":"12","author":"Mahabee-Gittens","year":"2019","journal-title":"Tob Use Insights"},{"issue":"10","key":"10.1016\/j.jcf.2024.07.010_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108258","article-title":"Thirdhand cigarette smoke: factors affecting exposure and remediation","volume":"9","author":"Bahl","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.010_bib0013","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/ntr\/ntv174","article-title":"Thirdhand smoke in the homes of medically fragile children: assessing the impact of indoor smoking levels and smoking bans","volume":"18","author":"Northrup","year":"2016","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S0022215100111648","article-title":"Impedance tympanometry and the home environment in seven-year-old children","volume":"104","author":"Strachan","year":"1990","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jcf.2024.07.010_bib0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2466-6-12","article-title":"Directly measured secondhand smoke exposure and COPD health outcomes","volume":"6","author":"Eisner","year":"2006","journal-title":"BMC Pulm Med"},{"issue":"8","key":"10.1016\/j.jcf.2024.07.010_bib0016","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1513\/AnnalsATS.201504-198OC","article-title":"Early childhood risk factors for decreased FEV1 at age six to seven years in young children with cystic fibrosis","volume":"12","author":"Sanders","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.010_bib0017","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/jama.299.4.417","article-title":"Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease","volume":"299","author":"Collaco","year":"2008","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2730","article-title":"Socioeconomic status, smoke exposure, and health outcomes in young children with cystic fibrosis","volume":"139","author":"Ong","year":"2017","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.010_bib0019","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jcf.2020.02.004","article-title":"Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis","volume":"19","author":"Oates","year":"2020","journal-title":"J Cyst Fibros"},{"issue":"10","key":"10.1016\/j.jcf.2024.07.010_bib0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13101003","article-title":"The impact of secondhand smoke exposure on children with cystic fibrosis: a review","volume":"13","author":"Kopp","year":"2016","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"10.1016\/j.jcf.2024.07.010_bib0021","doi-asserted-by":"crossref","first-page":"e39809","DOI":"10.1371\/journal.pone.0039809","article-title":"A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease","volume":"7","author":"Sloane","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jcf.2024.07.010_bib0022","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200508-1330OC","article-title":"Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers","volume":"173","author":"Cantin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.010_bib0023","doi-asserted-by":"crossref","first-page":"L894","DOI":"10.1152\/ajplung.00376.2004","article-title":"Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract","volume":"288","author":"Kreindler","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0024","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.11-192377","article-title":"Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration","volume":"26","author":"Clunes","year":"2012","journal-title":"Faseb J"},{"key":"10.1016\/j.jcf.2024.07.010_bib0025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1465-9921-10-120","article-title":"Secondhand smoke inhibits both Cl- and K+ conductances in normal human bronchial epithelial cells","volume":"10","author":"Savitski","year":"2009","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0026","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1165\/rcmb.2017-0432OC","article-title":"Vaporized E-cigarette liquids induce ion transport dysfunction in airway epithelia","volume":"61","author":"Lin","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.jcf.2024.07.010_bib0027","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12012-016-9396-5","article-title":"Acrolein can cause cardiovascular disease: a review","volume":"17","author":"Henning","year":"2017","journal-title":"Cardiovasc Toxicol"},{"issue":"9","key":"10.1016\/j.jcf.2024.07.010_bib0028","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1080\/02786826.2015.1076156","article-title":"A real-time fast-flow tube study of VOC and particulate emissions from electronic, potentially reduced-harm, conventional, and reference cigarettes","volume":"49","author":"Blair","year":"2015","journal-title":"Aerosol Sci Technol"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0029","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1165\/rcmb.2016-0226OC","article-title":"The cystic fibrosis transmembrane conductance regulator potentiator ivacaftor augments mucociliary clearance abrogating cystic fibrosis transmembrane conductance regulator inhibition by cigarette smoke","volume":"56","author":"Raju","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"11","key":"10.1016\/j.jcf.2024.07.010_bib0030","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/rccm.201304-0733OC","article-title":"Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function","volume":"188","author":"Raju","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0031","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12931-017-0656-0","article-title":"Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice","volume":"18","author":"Raju","year":"2017","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.jcf.2024.07.010_bib0032","doi-asserted-by":"crossref","first-page":"L530","DOI":"10.1152\/ajplung.00039.2013","article-title":"Cigarette smoke and CFTR: implications in the pathogenesis of COPD","volume":"305","author":"Rab","year":"2013","journal-title":"Am J Physiol Lung Cellular Mol Physiol"},{"issue":"11","key":"10.1016\/j.jcf.2024.07.010_bib0033","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1074\/jbc.M113.545137","article-title":"Cigarette smoke-induced Ca2+ release leads to cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction","volume":"289","author":"Rasmussen","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0034","doi-asserted-by":"crossref","first-page":"13655","DOI":"10.1038\/s41598-019-49544-9","article-title":"Cigarette smoke exposure induces retrograde trafficking of CFTR to the endoplasmic reticulum","volume":"9","author":"Marklew","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-15-18","article-title":"Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis","volume":"15","author":"Raju","year":"2014","journal-title":"Respir Res"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0036","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1378\/chest.13-0274","article-title":"Acquired CFTR dysfunction in the lower airways in COPD","volume":"144","author":"Dransfield","year":"2013","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0037","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1465-9921-15-25","article-title":"Acquired defects in CFTR-dependent Beta-adrenergic sweat secretion in chronic obstructive pulmonary disease","volume":"15","author":"Courville","year":"2014","journal-title":"Respir Res"},{"issue":"12","key":"10.1016\/j.jcf.2024.07.010_bib0038","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1164\/rccm.201502-0396LE","article-title":"Recovery of acquired Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) dysfunction following smoking cessation","volume":"192","author":"Courville","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.010_bib0039","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jcf.2020.09.011","article-title":"Tobacco smoke exposure limits the therapeutic benefit of tezacaftor\/ivacaftor in pediatric patients with cystic fibrosis","volume":"20","author":"Baker","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0040","first-page":"47","article-title":"Assessment of validity of self-reported smoking status","volume":"23","author":"Wong","year":"2012","journal-title":"Health Rep"},{"issue":"10","key":"10.1016\/j.jcf.2024.07.010_bib0041","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1158\/1055-9965.EPI-06-0393","article-title":"Validity of self-reported smoking status among participants in a lung cancer screening trial","volume":"15","author":"Studts","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0042","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1542\/peds.2010-2046","article-title":"Tobacco-smoke exposure in children who live in multiunit housing","volume":"127","author":"Wilson","year":"2011","journal-title":"Pediatrics"},{"issue":"9","key":"10.1016\/j.jcf.2024.07.010_bib0043","first-page":"1048","article-title":"Urine cotinine screening detects nearly ubiquitous tobacco smoke exposure in urban adolescents","volume":"19","author":"Benowitz","year":"2017","journal-title":"Nicotine Tob Res"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.010_bib0044","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/tx800479s","article-title":"Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers","volume":"22","author":"Carmella","year":"2009","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"10.1016\/j.jcf.2024.07.010_bib0045","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1021\/tx800468w","article-title":"Simultaneous determination of six mercapturic acid metabolites of volatile organic compounds in human urine","volume":"22","author":"Ding","year":"2009","journal-title":"Chem Res Toxicol"},{"issue":"7","key":"10.1016\/j.jcf.2024.07.010_bib0046","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/tx700075y","article-title":"Quantitation of acrolein-derived (3-hydroxypropyl)mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: effects of cigarette smoking","volume":"20","author":"Carmella","year":"2007","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"10.1016\/j.jcf.2024.07.010_bib0047","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/lary.23278","article-title":"Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein","volume":"122","author":"Alexander","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jcf.2024.07.010_bib0048","series-title":"National biomonitoring program NNAL factsheet","year":"2016"},{"issue":"3","key":"10.1016\/j.jcf.2024.07.010_bib0049","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/jes.2014.88","article-title":"Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012","volume":"26","author":"Wei","year":"2016","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"8","key":"10.1016\/j.jcf.2024.07.010_bib0050","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ntr\/ntp091","article-title":"Longer term exposure to secondhand smoke and health outcomes in COPD: impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol","volume":"11","author":"Eisner","year":"2009","journal-title":"Nicotine Tob Res"},{"issue":"7","key":"10.1016\/j.jcf.2024.07.010_bib0051","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1289\/ehp.1104413","article-title":"Exposure to secondhand smoke outside of a bar and a restaurant and tobacco exposure biomarkers in nonsmokers","volume":"120","author":"St Helen","year":"2012","journal-title":"Environ Health Perspect"},{"issue":"3","key":"10.1016\/j.jcf.2024.07.010_bib0052","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/tobaccocontrol-2011-050144","article-title":"Exposure to different sources of second-hand smoke during pregnancy and its effect on urinary cotinine and tobacco-specific nitrosamine (NNAL) concentrations","volume":"22","author":"Vardavas","year":"2013","journal-title":"Tob Control"},{"issue":"12","key":"10.1016\/j.jcf.2024.07.010_bib0053","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1158\/1055-9965.EPI-09-0874","article-title":"Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol","volume":"18","author":"Goniewicz","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.jcf.2024.07.010_bib0054","first-page":"590","article-title":"Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation","volume":"59","author":"Hecht","year":"1999","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcf.2024.07.010_bib0056","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","year":"2013","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.jcf.2024.07.010_bib0057","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.aca.2012.04.009","article-title":"Simultaneous analysis of 28 urinary VOC metabolites using ultra high performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (UPLC-ESI\/MSMS)","volume":"750","author":"Alwis","year":"2012","journal-title":"Anal Chim Acta"},{"issue":"21","key":"10.1016\/j.jcf.2024.07.010_bib0058","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1021\/ac8009005","article-title":"Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry","volume":"80","author":"Jacob","year":"2008","journal-title":"Anal Chem"},{"issue":"18","key":"10.1016\/j.jcf.2024.07.010_bib0059","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jcf.2024.07.010_bib0060","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jcf.2024.07.010_bib0061","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa1709847","article-title":"Tezacaftor-ivacaftor in residual-function heterozygotes with cystic fibrosis","volume":"377","author":"Rowe","year":"2017","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0062","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ppul.22945","article-title":"Sixty-five years since the New York heat wave: advances in sweat testing for cystic fibrosis","volume":"49","author":"Collie","year":"2014","journal-title":"Pediatr Pulmonol"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0063","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2024.07.010_bib0064","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.plabm.2018.01.001","article-title":"Revisiting sweat chloride test results based on recent guidelines for diagnosis of cystic fibrosis","volume":"10","author":"Pagaduan","year":"2018","journal-title":"Pract Lab Med"},{"key":"10.1016\/j.jcf.2024.07.010_bib0065","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.jpeds.2016.09.068","article-title":"Diagnosis of cystic fibrosis in nonscreened populations","volume":"181S","author":"Sosnay","year":"2017","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0066","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/toxsci\/kfw051","article-title":"Proposed mode of action for acrolein respiratory toxicity associated with inhaled tobacco smoke","volume":"151","author":"Yeager","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.jcf.2024.07.010_bib0067","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6567578","article-title":"Cigarette smoke-induced acquired dysfunction of cystic fibrosis transmembrane conductance regulator in the pathogenesis of chronic obstructive pulmonary disease","volume":"2018","author":"Shi","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"10.1016\/j.jcf.2024.07.010_bib0068","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1248\/bpb.b15-01022","article-title":"Recent progress in analytical methods for determination of urinary 3-hydroxypropylmercapturic acid, a major metabolite of acrolein","volume":"39","author":"Higashi","year":"2016","journal-title":"Biol Pharm Bull"},{"issue":"15","key":"10.1016\/j.jcf.2024.07.010_bib0069","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1089\/neu.2013.2888","article-title":"Determination of urine 3-HPMA, a stable acrolein metabolite in a rat model of spinal cord injury","volume":"30","author":"Zheng","year":"2013","journal-title":"J Neurotrauma"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.010_bib0070","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.3390\/biom5042987","article-title":"Alcohol, aldehydes, adducts and airways","volume":"5","author":"Sapkota","year":"2015","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.jcf.2024.07.010_bib0071","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/mnfr.200700412","article-title":"Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease","volume":"52","author":"Stevens","year":"2008","journal-title":"Mol Nutr Food Res"},{"issue":"2","key":"10.1016\/j.jcf.2024.07.010_bib0072","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/toxsci\/kfu233","article-title":"Molecular mechanisms of acrolein toxicity: relevance to human disease","volume":"143","author":"Moghe","year":"2015","journal-title":"Toxicol Sci"},{"issue":"13","key":"10.1016\/j.jcf.2024.07.010_bib0073","doi-asserted-by":"crossref","DOI":"10.3390\/foods11131976","article-title":"Origin and fate of acrolein in foods","volume":"11","author":"Jiang","year":"2022","journal-title":"Foods"},{"issue":"5-6","key":"10.1016\/j.jcf.2024.07.010_bib0074","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/10408449209146310","article-title":"Mercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals","volume":"22","author":"van Welie","year":"1992","journal-title":"Crit Rev Toxicol"},{"issue":"12","key":"10.1016\/j.jcf.2024.07.010_bib0075","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mnfr.201200323","article-title":"Profiling of mercapturic acids of acrolein and acrylamide in human urine after consumption of potato crisps","volume":"56","author":"Watzek","year":"2012","journal-title":"Mol Nutr Food Res"},{"issue":"9","key":"10.1016\/j.jcf.2024.07.010_bib0076","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1074\/jbc.M709417200","article-title":"Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog","volume":"283","author":"Bompadre","year":"2008","journal-title":"J Biol Chem"},{"issue":"44","key":"10.1016\/j.jcf.2024.07.010_bib0077","doi-asserted-by":"crossref","first-page":"36639","DOI":"10.1074\/jbc.M112.393637","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner","volume":"287","author":"Eckford","year":"2012","journal-title":"J Biol Chem"},{"issue":"10212","key":"10.1016\/j.jcf.2024.07.010_bib0078","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.jcf.2024.07.010_bib0079","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jcf.2024.07.010_bib0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.jcf.2024.07.010_bib0081","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jcf.2021.06.014","article-title":"Cessation of smoke exposure improves pediatric CF outcomes: longitudinal analysis of CF Foundation Patient Registry data","volume":"20","author":"Oates","year":"2021","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932400794X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156919932400794X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:14:46Z","timestamp":1788246886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156919932400794X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S156919932400794X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2024.07.010","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2024.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}